Visual Universitätsmedizin Mainz

Schriftenverzeichnis Univ.-Prof. Dr. C. Behl

 

1. ORIGINALARBEITEN & ÜBERSICHTSARTIKEL


2017

Behl C (2017).
Amyloid in Alzheimer's Disease: Guilty Beyond Reasonable Doubt?
Trends Pharmacol Sci. 2017 Aug 18 [Epub ahead of print]

Reilly R, Mroz MS, Dempsey E, Wynne K, Keely SJ, McKone EF, Hiebel C, Behl C, Coppinger JA (2017).
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis.
Sci Rep. 7(1):7642.

Stürner E, Behl C (2017).
The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease.
Front Mol Neurosci. 10:177.

Feldmann A, Bekbulat F, Huesmann H, Ulbrich S, Tatzelt J, Behl C, Kern A (2017).
The RAB GTPase RAB18 modulates macroautophagy and proteostasis.
Biochem Biophys Res Commun. 486(3):738-743.

Schönbühler B, Schmitt V, Huesmann H, Kern A, Gamerdinger M, Behl C (2017).
BAG2 Interferes with CHIP-Mediated Ubiquitination of HSP72.
Int. J. Mol. Sci. 18(1), 69.

2016

Behl C (2016).
Breaking BAG: The Co-Chaperone BAG3 in Health and Disease.
Trends Pharmacol Sci. 37(8):672-88.

Rodríguez AE, López-Crisosto C, Peña-Oyarzún D, Salas D, Parra V, Quiroga C, Morawe T, Chiong M, Behl C, Lavandero S (2016).
BAG3 regulates total MAP1LC3B protein levels through a translational but not transcriptional mechanism.
Autophagy. 12(2):287-96.

Klionsky DJ, (...), Behl C, (...), Kern A, (...) (2016).
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy. 12(1):1-222.

Khaminets A, Behl C, Dikic I (2016).
Ubiquitin-Dependent And Independent Signals In Selective Autophagy.
Trends Cell Biol. 26(1):6-16.

Kundu A, Milosch N, Antonietti P, Baumkötter F, Zymny A, Müller UC, Kins S, Hajieva P, Behl C, Kögel D (2015).
Modulation of BAG3 Expression and Proteasomal Activity by sAPPα Does Not Require Membrane-Tethered Holo-APP.
Mol Neurobiol. 53(9):5985-5994.

2015

Kern A, Dikic I, Behl C (2015).
The integration of autophagy and cellular trafficking pathways via RAB GAPs.
Autophagy. 11(12):2393-7.

Felzen V, Hiebel C, Koziollek-Drechsler I, Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C, Morawe T (2015).
Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Cell Death Dis. 6:e1812.

Hiebel C, Behl C (2015).
The complex modulation of lysosomal degradation pathways by cannabinoid receptors 1 and 2.
Life Sci. 2015 Apr 20. [Epub ahead of print]

Meister S, Storck SE, Hameister E, Behl C, Weggen S, Clement AM, Pietrzik CU (2015).
Expression of the ALS-causing variant hSOD1G93A leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
J Cereb Blood Flow Metab. 35(7):1112-21.

Liebl MP, Windschmitt J, Besemer AS, Schäfer AK, Reber H, Behl C, Clement AM (2015).
Low-frequency magnetic fields do not aggravate disease in mouse models of Alzheimer's disease and amyotrophic lateral sclerosis.
Sci Rep. 5:8585.

Granold M, Moosmann B, Staib-Lasarzik I, Arendt T, Del Rey A, Engelhard K, Behl C, Hajieva P (2015).
High membrane protein oxidation in the human cerebral cortex.
Redox Biol. 4:200-7.

Renziehausen J, Hiebel C, Nagel H, Kundu A, Kins S, Kögel D, Behl C, Hajieva P (2015).
The Cleavage Product of Amyloid-β Protein Precursor sAβPPα Modulates BAG3-Dependent Aggresome Formation and Enhances Cellular Proteasomal Activity.
J Alzheimers Dis. 44(3):879-96.

Pasillas MP, Shields S, Reilly R, Strnadel J, Behl C, Park R, Yates JR 3rd, Klemke R, Gonias SL, Coppinger JA (2015).
Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and Major Vault Protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.
Mol Cell Proteomics. 14(1):1-14.

Hajieva P, Bayatti N, Granold M, Behl C, Moosmann B (2015)
Membrane protein oxidation determines neuronal degeneration.
J Neurochem. 133(3):352-67.

2014

Spang N*, Feldmann A*, Huesmann H, Bekbulat F, Schmitt V, Hiebel C, Koziollek-Drechsler I, Clement AM, Moosmann B, Jung J, Behrends C, Dikic I, Kern A, Behl C (2014) (* equal contribution)
RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy.
Autophagy. 10(12):2297-309.

Milosch N, Tanriöver G, Kundu A, Rami A, François JC, Baumkötter F, Weyer SW, Samanta A, Jäschke A, Brod F, Buchholz CJ, Kins S, Behl C, Müller UC, Kögel D (2014).
Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.
Cell Death Dis. 5:e1391.

Hiebel C, Kromm T, Stark M, Behl C (2014).
Cannabinoid receptor 1 modulates the autophagic flux independent of mTOR- and BECLIN1-complex.
J Neurochem. 131(4): 484-97.

Stark M, Behl C (2014).
The Ginkgo biloba Extract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation.
Evidence-Based Complementary and Alternative Medicine 2014:940186.

Liebl MP, Kaya AM, Tenzer S, Mittenzwei R, Koziollek-Drechsler I, Schild HR, Moosmann B, Behl C, Clement AM (2014).
Dimerization of visinin-like protein 1 is regulated by oxidative stress and calcium and is a pathological hallmark of amyotrophic lateral sclerosis.
Free Radic Biol Med. 72:41-54.

Brendel A, Renziehausen J, Behl C, Hajieva P (2014).
Downregulation of PMCA2 increases the vulnerability of midbrain neurons to mitochondrial complex I inhibition.
Neurotoxicology 40:43-51.

2013

Weichert A, Besemer AS, Liebl M, Hellmann N, Koziollek-Drechsler I, Ip P, Decker H, Robertson J, Chakrabartty A, Behl C, Clement AM (2013).
Wild-type Cu/Zn superoxide dismutase stabilizes mutant variants by heterodimerization.
Neurobiol Dis. 62:479-488.

Blödt S, Kuhlmey A, Bartholomeyczik S, Behl C, Betsch F, Brinkhaus B, Frühwald M, Füsgen I, Jansen S, Köppel C, Krüger E, Macher M, Michalsen A, Rapp MA, Riepe MW, Schimpf D, Teut M, Warme B, Warning A, Wilkens J, Witt CM (2013).
Dementia in Germany: Results of an interdisciplinary expert workshop.]
Wien Med Wochenschr. 163:536-40. German.

Stumm C, Hiebel C, Hanstein R, Purrio M, Nagel H, Conrad A, Lutz B, Behl C, Clement AB (2013).
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Neurobiol Aging. 34(11): 2574-84.

Brendel A, Felzen V, Morawe T, Manthey D, Behl C (2013).
Differential regulation of apoptosis-associated genes by estrogen receptor alpha in human neuroblastoma cells.
Restor Neurol Neurosci. 31: 199-211.

Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J, Dikic I (2013).
Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates.
J Cell Sci. 126: 580-92.

2012

Büchner B, Gallenmüller C, Lautenschläger R, Kuhn K, Wittig I, Schöls L, Rapaport D, Seelow D, Freisinger P, Prokisch H, Sperl W, Wenz T, Behl C, Deschauer M, Kornblum C, Schneiderat P, Abicht A, Schuelke M, Meitinger T, Klopstock T und und das mitoNET-Consortium (2012).
Das Deutsche Netzwerk für mitochondriale Erkrankungen (mitoNET).
Medizinische Genetik 24: 193-199.

Klionsky DJ, (...), Behl C, (...) (2012).
Guidelines for the use and interpretation of assays for monitoring autophagy.
Autophagy 8: 445-544.

Behl C (2012).
Brain aging and late-onset Alzheimer's disease: many open questions.
Int Psychogeriatr. 24 Suppl 1: S3-9.

Morawe T, Hiebel C, Kern A, Behl C (2012).
Protein Homeostasis, Aging and Alzheimer's Disease.
Mol Neurobiol. 46(1):41-54.

Kögel D, Deller T, Behl C (2012).
Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging.
Exp Brain Res. 217:471-9.

2011

Gamerdinger M, Carra S, Behl C (2011)
Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins.
J Mol Med (Berl). 89:1175-82.

Behl C (2011)
BAG3 and friends: Co-chaperones in selective autophagy during aging and disease.
Autophagy 7(7):795-8.

Schindeldecker M, Stark M, Behl C, Moosmann B (2011)
Differential cysteine depletion in respiratory chain complexes enables the distinction of longevity from aerobicity.
Mech. Ageing Dev. 132:171-179.

Gamerdinger M, Kaya AM, Wolfrum U, Clement AM, Behl C (2011)
BAG3 mediates chaperone-based aggresome-targeting and selected autophagy of misfolded proteins.
EMBO Rep. 12(2):149-56.

2010

Mocko JB, Kern A, Moosmann B, Behl C, Hajieva P (2010)
Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease.
Neurobiol Dis 40(1): 120-9.

Haege S, Galetzka D, Zechner U, Haaf T, Gamerdinger M, Behl C, Hiemke C, Schmitt U (2010)
Spatial learning and expression patterns of PP1 mRNA in mouse hippocampus.
Neuropsychobiology 61(4): 188-96.

Clement AB, Gimpl G, Behl C (2010)
Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein.
Free Radic Biol Med 48(9): 1236-1241.

Luh C, Kuhlmann CR, Ackermann B, Timaru-Kast R, Luhmann HJ, Behl C, Werner C, Engelhard K, Thal SC (2010)
Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
J Neurochem 112(4): 1015-1025.

Manthey D, Gamerdinger M, Behl C (2010)
The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities.
Br J Pharmacol 159(6): 1264-1273.

Kern A, Ackermann B, Clement, AM, Dürk H, Behl C (2010)
HSF1-controlled and age-associated chaperone capacity in neurons and muscle cells of C.elegans.
PLoS ONE 5(1): e8568.

2009

Witan H, Gorlovoy P, Kaya AM, Koziollek-Drechsler I, Neumann H, Behl C, Clement AM (2009)
Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1.
Neurobiol. Disease 36, 331-342.

Clement AB, Gamerdinger M, Tamboli IY, Lütjohann D, Walter J, Greeve I, Gimpl G, Behl C (2009)
Adaptation of neuronal cells to chronic oxidative stress is associated with altered lipid homeostasis and lysosomal function.
J. Neurochem. 111, 669-82.

Kern A, Behl C (2009)
The unsolved relationship of brain aging and late-onset Alzheimer disease.
Biochim. Biophys. Acta 1790(10): 1124-1132.

Bondesson M, Jönsson J, Pongratz I, Olea N, Cravedi JP, Zalko D, Håkansson H, Halldin K, Di Lorenzo D, Behl C, Manthey D, Balaguer P, Demeneix B, Fini JB, Laudet V, Gustafsson JÅ (2009)
A CASCADE of effects of bisphenol A.
Reprod. Toxicol. 28(4): 563-567.

Hajieva P, Mocko JB, Moosmann B, Behl C (2009)
Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
J. Neurochem. 110(1): 118-132.

Hanstein R, Trotter J, Behl C, Clement AB (2009)
Increased connexin 43 expression as a potential mediator of the neuroprotective activity of the corticotropin-releasing hormone.
Mol. Endocrinol. 23(9): 1479-1493.

Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FU, Behl C (2009)
Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3.
EMBO J 28(7): 889-901.

Hajieva P, Kuhlmann C, Luhmann HJ, Behl C (2009)
Impaired Calcium Homeostasis in Aged Hippocampal Neurons.
Neurosci. Lett. 451(2): 119-123.

2008

Hanstein R, Lu A, Wurst W, Holsboer F, Deussing JM, Clement, AB, Behl C (2008)
Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.
Neuroscience 156, 712-721.

Waldron E, Isbert S, Kern A, Jaeger S, Martin AM, Hébert SS, Behl C, Weggen S, De Strooper B, Pietrzik CU (2008)
Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription.
Exp. Cell Res. 314, 2419-2433.

Gamerdinger M, Clement AB, Behl C (2008)
Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
Neuropharmacology 54(6): 998-1005.

Clement AB, Hanstein R, Schröder A, Nagel H, Endres, K, Fahrenholz F, Behl C (2008)
Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Neuroscience 152(2): 459-468.

Witan H, Kern A, Koziollek-Drechsler I, Wade R, Behl C, Clement AM (2008)
Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.
Hum. Mol. Genet. 17 (10): 1373-1385.

Moosmann B, Behl C (2008)
Mitochondrially encoded cysteine predicts animal lifespan.
Aging Cell 7(1): 32-46.

2007

Ebinger M, Behl C, Rosenhagen M, Uhr M (2007)
P-Glycoprotein has negligible effects on estradiol and testosterone in mice.
Neurosci. Lett. 427, 6-9.

Gamerdinger M, Clement AB, Behl C (2007)
Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production.
Mol Pharmacol 72(1): 141-151.

Kuhlmann CRW, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, Luhmann HJ (2007)
Inhibition of the myosin light chain kinase prevents hypoxia-induced blood brain barrier disruption.
J Neurochem 102(2): 501-507.

2006

Behl C (2006)
The search for novel avenues for the therapy and prevention of Alzheimer’s disease.
Drug News Perspect 19, 5-12.

Gamerdinger M, Manthey D, Behl C (2006)
Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells – implications for neuroprotection against Ca2+-mediated excitotoxicity.
J Neurochem 97(1), 57-68.

Hajieva P, Behl C (2006)
Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid beta toxicity and Alzheimer’s disease.
Curr Pharm Design 12(6), 699-704.

Manthey D, Behl C (2006)
From structural biochemistry to expression profiling: Neuroprotective activities of estrogen.
Neuroscience 138(3), 845-850.

Kern A, Roempp B, Prager K, Walter J, Behl C (2006)
Down-regulation of endogenous amyloid precursor protein processing due to cellular aging.
J Biol Chem 281(5), 2405-2413.

2005

Zschocke J, Bayatti N, Clement AM, Witan H, Figiel M, Engele J, Behl C (2005)
Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions.
J Biol Chem 280, 34924-34932.

Ludemann N, Clement A, Hans VH, Leschik J, Behl C, Brandt R (2005) O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS)
J Biol Chem 280, 31648-31658.

Bayatti N, Behl C (2005)
The neuroprotective actions of corticotropin releasing hormone.
Aging Res Rev 4, 258-270.

Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C (2005)
Glycogen synthase kinase 3ß links neuroprotection by 17ß-estradiol to key Alzheimer processes.
Neuroscience 132, 581-589.

Pietrzik C, Behl C (2005)
Concepts for the treatment of Alzheimer’s disease: molecular mechanisms and clinical application.
Int J Exp Pathol 86, 173-185.

Behl C (2005)
Oxidative stress in Alzheimer’s disease: implications for prevention and therapy.
Subcellular Biochemistry 38, 65-78.

Zschocke J, Bayatti N, Behl C (2005)
Caveolin and GLT-1 gene expression is reciprocally regulated in primary astrocytes: association of GLT-1 with non-caveolar lipid rafts.
Glia 49, 275-287.

Bayatti N, Hermann H, Lutz B, Behl C (2005)
Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system.
Endocrinology 146, 1205-1213.

2004

Moosmann B, Behl C (2004)
Selenoproteins, cholesterol-lowering drugs, and the consequences: Revisiting of the mevalonate pathway.
Trends Cardiovas Med 14, 273-281.

Zitzler J, Link D, Schäfer R, Liebetrau W, Kazinski M, Bonin-Debs A, Behl C, Buckel P, Brinkmann U (2004)
High-throughput functional genomics identifies genes that ameliorate toxicity due to oxidative stress in neuronal HT-22 cells: GFPT2 protects cells against peroxide.
Mol Cell Proteomics 3, 834-840.

Schäfer M, Goodenough S, Moosmann B, Behl C (2004)
Inhibition of glycogen synthase kinase 3ß is involved in the resistance to oxidative stress in neuronal HT22 cells.
Brain Res 1005, 84-89.

Moosmann B, Behl C (2004)
Selenoprotein synthesis and side-effects of statins.
Lancet 363, 892-894.

van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT (2004)
Estrogen receptor (ER) -mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERα and ERβ.
Mol Endocrinol 18, 2908-2923.

Goodenough S, Conrad S, Skutella T, Behl C (2004) Inactivation of glycogen synthase kinase-3 protects against kainic acid-induced neurotoxicity in vivo.
Brain Res 1026, 116-125.

2003

Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C*, Lutz B* (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity.
Science 302: 84-88 (*co-corresponding authors).

Bayatti N, Zschocke J, Behl C (2003)
Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons.
Endocrinology, 144: 4051-4060.

Goodenough S, Schäfer M, Behl C (2003)
Estrogen-induced cell signalling in a cellular model of Alzheimer's disease.
J Steroid Biochem 84: 301-305.

Zschocke J, Manthey D, Bayatti N, Behl C (2003)
Functional interaction of estrogen receptor alpha and caveolin isoforms in neuronal SK-N-MC cells.
J Steroid Biochem 84: 167-170.

C Behl (2003)
Molecular Aging Research.
unter: www.springer.de

2002

Behl C (2002)
Estrogen can protect neurons: modes of action.
J Steroid Biochem 83: 195-197.

Behl C (2002)
Neuroprotective strategies in Alzheimer’s disease.
Adv Exp Med Biol, 513: 475-496.

Behl C (2002)
Sex hormones, neuroprotection and cognition.
Prog Brain Res 138:135-142.

Moosmann B, Behl C (2002)
Antioxidants as treatment for neurodegenerative disorders.
Expert Opin Inv Drug 11:1407-1435.

Zschocke J, Manthey D, Bayatti N, van der Burg B, Goodenough S, Behl C (2002)
Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells.
J Biol Chem 277:38772-38780.

Behl C (2002)
Estrogen as a neuroprotective hormone.
Nat Rev Neurosci 3: 433-442.

Behl C, Moosmann B (2002)
Oxidative nerve cell death in Alzheimer’s disease and stroke: antioxidants as neuroprotective compounds.
Biol Chem 383: 521-536.

Behl C, Moosmann B (2002)
Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach.
Free Radical Bio Med 33: 182-191.

Moosmann B, Behl C (2002)
Secretory peptide hormones are biochemical antioxidants: structure-activity relationship.
Mol Pharmacol 61: 260-268.

Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.
J Neurochem 80: 448-456.

2001

Moosmann B, Skutella T, Beyer K, Behl C (2001)
Protective activity of aromatic amines and imines against oxidative nerve cell death.
Biol Chem 382: 1601-1612.

Behl C, Moosmann B (2001)
Östrogene
Nachr Chem 49: 332-336.

Yamamoto A, Behl C (2001)
Human Nck-associated protein1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation.
Neurosci Lett 316: 50-54.

Jahn H, Kiefer F, Behl C, Wiedemann K (2001)
Activation of guanylatecyclase by natriuretic peptides in mouse pituitary AtT20 cells is influenced by phosphorylation of ANP.
Neurochem Res 26: 473-478.

Manthey D, Heck S, Engert S, Behl C (2001)
Estrogen induces a rapid release of non-amyloidogenic amyloid ß precursor protein (APP) via the mitogen-activated-protein- (MAP-) kinase pathway.
Eur J Biochem 267: 5687-5692.

2000

Wolozin B, Behl C (2000)
Mechanisms of Neurodegenerative Disorders
Part 1: Protein Aggregates
Arch Neurol 57: 793-796.

Wolozin B, Behl C (2000)
Mechanisms of Neurodegenerative Disorders
Part 2: Control of Cell Death
Arch Neurol 57: 801-804.

Goodenough S, Engert S, Behl C (2000)
Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway.
Neurosci Lett 296: 49-52.

Behl C (2000)
Apoptosis and Alzheimer‘s Disease.
J Neural Transm 107:1325-1344.

Braun S, Liebetrau W, Berning B, Behl C (2000)
Vulnerability of clonal hippocampal cells to oxidative stress is increased by dexamethasone and associated with suppression of NF-B.
Neurosci Lett 295: 101-104.

Post A, Crochemore C, Uhr M, Holsboer F, Behl C (2000)
Differential induction of NF-B activity and neural cell death by antidepressants in vitro.
Eur J Neurosci 12: 4331-4337.

Klostermann A, Lutz B, Gertler F, Behl C (2000)
The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the Enabled/Vasodilator-stimulated Phosphoprotein-like Protein (EVL) via a novel carboxyterminal Zyxin-like domain.
J Biol Chem 275: 39647-39653.

Moosmann B, Behl C (2000)
Dietary phenols: Antioxidants for the brain?
Nutr Neurosci (Invited Comment) 3: 1-10.

Greeve I, Hermans-Borgmeyer I, Fehr S, Brellinger C, Gomez-Isla T, Hyman BT, Behl C, Levkau B, Nitsch RM (2000)
Expression of seladin-1 -a novel neuroprotective gene with homology to oxido-reductases- is associated with selective vulnerability in Alzheimer’s disease.
J Neurosci 20: 7345-7352.

Moosmann B, Behl C (2000)
Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins.
Eur J Biochem 267: 5687-5692.

Lezoualc’h F, Engert S, Berning B, Behl C (2000)
Corticotropin-releasing factor-mediated neuroprotection is associated with increased release of non-amyloidogenic amyloid ß protein precursor and with the suppression of NF-B.
Mol Endocrinol 14: 147-159.

1999

Heck S, Lezoualc’h F, Engert S, Behl C (1999)
Insulin-like growth factor-1-mediated neuroprotection against oxidative
stress is associated with activation of NF-

 

2. BÜCHER

 

Behl C & Ziegler C (2016)
Molekulare Mechanismen der Zellalterung und ihre Bedeutung für Alterserkrankungen des Menschen.
Springer Berlin Heidelberg, ISBN 3-662-48249-0.

Behl C & Ziegler C (2014)
Cell Aging: Molecular Mechanisms and Implications for Disease.
Springer Berlin Heidelberg, ISBN 3-642-45178-0.

Behl C (2001)
Estrogen – Mystery Drug for the Brain? The Neuroprotective Activities of the Female Sex Hormone.
Springer Wien/New York, ISBN 3-211-83539-3.

 

3. BUCHKAPITEL

2013

Behl C (2013)
The role of the co-chaperone BAG3 in selective macroautophagy: implications for aging and disease.
In: Protein Quality Control in Neurodegenerative Diseases. R.I. Morimoto and Y. Christen (ed.).
Springer-Verlag Berlin Heidelberg, 87-96

2008

Behl C, Moosmann B (2008)
Molekulare Mechanismen des Alterns. Über das Altern der Zellen und den Einfluss von oxidativem Stress auf den Alternsprozess.
In: Was ist Alter(n)? Neue Antworten auf eine scheinbar einfache Frage. (U.M. Staudinger, H. Häfner (eds.).
Spinger-Verlag Berlin Heidelberg, 9-32 [Schriften der Mathematisch-naturwissenschaftlichen Klasse der Heidelberger Akademie der Wissenschaften, Nr. 18, 2008]

Behl C (2008)
Morbus Alzheimer und weitere neurodegenerative Erkrankungen.
In: Handbuch der Psychopharmakotherapie. F. Holsboer, G. Gründer, O. Benkert (eds.).
Springer Medizin Verlag Heidelberg, 236-247

2007

Behl C, Hartl FU (2007)
Molekulare Mechanismen des Alterns.
In: Die Zukunft des Alterns. Peter Gruss (ed.). Die Antwort der Wissenschaft. Ein Report der Max-Planck-Gesellschaft.
C.H. Beck, 101-136

2005

Behl C (2005)
Oxidative stress in Alzheimer’s Disease: Implications for prevention and therapy.
In: Subcellular Biochemistry 38: Alzheimer’s Disease. Cellular and Molecular Aspects of Amyloid ß. Harris/Fahrenholz (ed.).
Springer Verlag, 65-78

Behl C (2005)
Modulators of endogenous neuroprotection: estrogen, corticotropin-releasing hormone and endocannabinoids.
In: Hormones and the Brain. C. Kordon, R.C. Gaillard, Y. Christen (ed.).
Springer-Verlag Berlin Heidelberg, 201-212
[Research and Perspectives in Endocrine Interactions. Fondation Ipsen]

2004

Behl C (2004)
Freie Radikale.
In: Neurodegenerative Erkrankungen des Alters. Winkler/Ludoph (ed.).
Thieme, 3-14

Behl C (2004)
Proteinaggregation und Neurodegeneration.
In: Neurodegenerative Erkrankungen des Alters. Winkler/Ludoph (ed.).
Thieme, 31-34

Behl C (2004)
Molekulare Grundlagen des Alterns - eine Einführung
In: Molekulare Medizin, Band 13 - Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen. Ganten/Ruckpaul (ed.).
Springer Verlag, 67-86

2003

Behl C (2003)
Neuroprotective strategies in Alzheimer’s disease.
In: Molecular and Cellular Biology of Neuroprotection in the CNS. Alzheimer C. (ed.).
Kluwer Academic / Plenum Publishers / Landes Bioscience / Eurekah.com, 475-496

2002

C. Behl (2002)
Neuroprotective effects of estrogens in the central nervous system: mechanisms of action.
In: Risk and protective Factors in Schizophrenia: Towards a Conceptual Model of the Disease Process, H. Häfner (Ed.),
Springer, Steinkopff, Darmstadt: 263-270.

Behl C (2002)
Oxidativer Streß im Gehirn und antioxidativer Nervenzellschutz durch Phenole
In: Vitamine, Spurenelemente und Mineralstoffe. Biesalski, Köhrle, Schümann (eds.),
Thieme Verlag, Stuttgart: 532-537.

2000

Behl C, Moosmann B, Manthey D, Heck S (2000)
The female sex hormone estrogen as neuroprotectant: activities at various levels.
In: Neuronal and cognitive effects of estrogens. Novartis (previously CIBA) Foundation Symposium 230. Sussex UK:
John Wiley & Sons Ltd.: 221-238.

1999

Behl C, Moosmann B (1999)
Freie Radikale und Antioxidantien.
In: Grundlagen der klinischen Neuroprotektion. Schwarz J, Ludolph AC (eds.).
Reihe UNI-MED Science, UNI-MED Verlag.

Behl C (1999)
Oxidativer Streß, Neurodegeneration und Neuroprotektion im zellulären Modell.
Habilitation an der Ludwig-Maximilians-Universität München.

Behl C, Moosmann B (1999)
Estrogens and other antioxidants in neuroprotection: implications for Alzheimer’s disease.
In: Free Radicals in Brain Pathophysiology. Poli G, Packer L, Cadenas E (eds.)
New York, Basel: Marcel Dekker, Inc.: 467-485.

Lezoualc´h F, Behl C (1999)
The role of estrogens and NF-B in neuroprotection against oxidative stress.
In: Alzheimer’s Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics. Iqbal K, Swaab D, Winblad B, Wisniewski HM (eds.) Chichester:
John Wiley & Sons: 697-706

1992-1996

Skutella T, Probst J-C, Behl C, Holsboer F (1996)
Antisense targeting of corticotropin-releasing hormone and corticotropin-releasing hormone receptor type I.
In: Application of Antisense Strategies for Investigation of Receptor mechanisms in vivo and in vitro. Porreca F, Raffa R (eds.).
Landes Biomedical Publishers: 153-173

Davis JB, Behl C, Klier FG, Schubert (1995)
Amyloid ß peptide causes necrotic cell death in PC12 cells.
In: Alzheimer’s Disease: Lessions from Cell Biology. Kosik KS, Christen Y, Selkoe DJ (eds.)
Paris: Foundation IPSEN: 217-229

Behl C (1992)
Autokrine Regulationsmechanismen eines humanen malignen Melanoms und partielle Charakterisierung eines Melanom-assoziierten Proteins.
Dissertation an der Julius-Maximilians-Universität Würzburg